Ratings by Jefferies (Eun Yang)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/2/2026 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2025 | Generation Bio | GBIO | Downgrade | Hold (Buy) |
5.43 (5.34) |
-1.66% | Details | |
| 11/19/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | Rigel Pharmaceuticals | RIGL | Upgrade | Buy (Hold) |
28.38 (28.87) |
1.73% | Details | |
| 10/29/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2025 | Astria Therapeutics | ATXS | Downgrade | Hold (Buy) |
8.47 (12.58) |
48.52% | Details | |
| 10/2/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 9/2/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2025 | Generation Bio | GBIO | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2025 | Rigel Pharmaceuticals | RIGL | Maintain | Hold (N/A) |
|
Details | ||
| 5/7/2025 | Rigel Pharmaceuticals | RIGL | Maintain | Hold (N/A) |
|
Details | ||
| 4/15/2025 | Verve Therapeutics | VERV | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2024 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2024 | Dyne Therapeutics | DYN | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2024 | Aerovate Therapeutics Inc | AVTE | Downgrade | Hold (Buy) |
24.62 (2.68) |
-89.11% | Details | |
| 5/14/2024 | Taysha Gene Therapies | TSHA | New Coverage | Buy (Hold) |
2.34 (4.57) |
95.3% | Details | |
| 5/9/2024 | Verve Therapeutics | VERV | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2024 | Deciphera | DCPH | Downgrade | Hold (Buy) |
14.65 (25.59) |
74.68% | Details | |
| 3/25/2024 | Aerovate Therapeutics Inc | AVTE | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2024 | Rallybio Corp. | RLYB | Downgrade | Hold (Buy) |
1.25 (10.91) |
772.8% | Details | |
| 12/15/2023 | Reneo Pharmaceuticals | RPHM | Downgrade | Hold (Buy) |
7.75 (1.82) |
-76.52% | Details | |
| 8/15/2023 | Aerovate Therapeutics Inc | AVTE | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2023 | Translate Bio | TBIO | Maintain | Buy (N/A) |
|
Details | ||
| 7/18/2023 | BridgeBio Pharma | BBIO | Downgrade | Hold (Buy) |
18.22 (46.27) |
153.95% | Details | |
| 7/12/2023 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2023 | Biomea Fusion Inc. | BMEA | Downgrade | Hold (Buy) |
30.67 (1.86) |
-93.94% | Details | |
| 5/4/2023 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2023 | Enliven Therapeutics | ELVN | New Coverage | Buy (N/A) |
23.10 (29.44) |
27.45% | Details | |
| 2/23/2023 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2023 | Taysha Gene Therapies | TSHA | Downgrade | Hold (Buy) |
1.54 (2.34) |
51.95% | Details | |
| 1/24/2023 | Paratek Pharmaceuticals | PRTK | Maintain | Buy (N/A) |
|
Details | ||
| 1/11/2023 | Albireo Pharma | ALBO | Downgrade | Hold (Buy) |
43.85 (44.15) |
0.68% | Details | |
| 1/9/2023 | CureVac | CVAC | Maintain | Buy (Hold) |
|
Details | ||
| 12/16/2022 | Astria Therapeutics | ATXS | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2022 | Lumos Pharma | LUMO | Downgrade | Hold (Buy) |
4.83 (4.34) |
-10.14% | Details | |
| 11/14/2022 | Lumos Pharma | LUMO | Downgrade | Hold (Buy) |
8.91 (4.34) |
-51.29% | Details | |
| 11/14/2022 | Prime Medicine | PRME | New Coverage | Buy (N/A) |
20.57 (5.40) |
-73.75% | Details | |
| 11/9/2022 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | Rallybio Corp. | RLYB | Maintain | Buy (N/A) |
|
Details | ||
| 9/22/2022 | NuCana | NCNA | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2022 | Rigel Pharmaceuticals | RIGL | Downgrade | Hold (Buy) |
1.76 (28.38) |
1512.5% | Details | |
| 5/24/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2022 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Albireo Pharma | ALBO | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2022 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 12/27/2021 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2021 | Pyxis Oncology Inc. | PYXS | New Coverage | Buy (N/A) |
13.34 (4.31) |
-67.69% | Details | |
| 10/20/2021 | Radius Health | RDUS | Maintain | Hold (N/A) |
|
Details | ||
| 10/4/2021 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2021 | Astria Therapeutics | ATXS | New Coverage | Buy (N/A) |
9.53 (12.58) |
32% | Details | |
| 8/23/2021 | Rallybio Corp. | RLYB | New Coverage | Buy (N/A) |
12.92 (10.91) |
-15.56% | Details | |
| 8/3/2021 | Translate Bio | TBIO | Downgrade | Hold (Buy) |
29.15 (3.23) |
-88.92% | Details | |
| 7/26/2021 | Aerovate Therapeutics Inc | AVTE | New Coverage | Buy (N/A) |
14.23 (24.62) |
73.01% | Details | |
| 7/15/2021 | Generation Bio | GBIO | Maintain | Buy (N/A) |
|
Details | ||
| 7/12/2021 | Verve Therapeutics | VERV | New Coverage | Buy (N/A) |
46.25 (6.27) |
-86.44% | Details | |
| 7/8/2021 | Nabriva Therapeutics AG | NBRV | New Coverage | Hold (N/A) |
1.27 (1.42) |
11.81% | Details | |
| 6/22/2021 | Centessa Pharmaceuticals | CNTA | New Coverage | Buy (N/A) |
24.91 (25.95) |
4.18% | Details | |
| 6/9/2021 | Cogent | COGT | New Coverage | Buy (N/A) |
7.85 (37.08) |
372.36% | Details | |
| 5/11/2021 | Taysha Gene Therapies | TSHA | New Coverage | Buy (N/A) |
20.52 (4.57) |
-77.73% | Details | |
| 5/11/2021 | Biomea Fusion Inc. | BMEA | New Coverage | Buy (N/A) |
16.94 (1.39) |
-91.79% | Details | |
| 5/4/2021 | Reneo Pharmaceuticals | RPHM | New Coverage | Buy (N/A) |
14.40 (1.82) |
-87.36% | Details | |
| 4/8/2021 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2021 | Albireo Pharma | ALBO | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2021 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2021 | Five Prime Therapeutics | FPRX | Downgrade | Hold (Buy) |
21.26 (38.00) |
78.74% | Details | |
| 3/2/2021 | Paratek Pharmaceuticals | PRTK | New Coverage | Buy (N/A) |
7.48 (2.23) |
-70.19% | Details | |
| 1/27/2021 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 10/12/2020 | Dyne Therapeutics | DYN | New Coverage | Buy (N/A) |
18.99 (14.86) |
-21.75% | Details | |
| 9/8/2020 | Albireo Pharma | ALBO | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2020 | CureVac | CVAC | New Coverage | Hold (N/A) |
56.92 (4.07) |
-92.85% | Details | |
| 8/14/2020 | Lumos Pharma | LUMO | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | Radius Health | RDUS | Maintain | Hold (N/A) |
|
Details | ||
| 8/11/2020 | Halozyme Therapeutics | HALO | Maintain | Underperform (N/A) |
|
Details | ||
| 8/7/2020 | Translate Bio | TBIO | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2020 | Generation Bio | GBIO | New Coverage | Buy (N/A) |
19.56 (5.43) |
-72.24% | Details | |
| 5/18/2020 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2020 | Deciphera | DCPH | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2020 | Halozyme Therapeutics | HALO | Maintain | Underperform (N/A) |
|
Details | ||
| 4/16/2020 | Lumos Pharma | LUMO | New Coverage | Buy (N/A) |
9.21 (4.34) |
-52.88% | Details | |
| 3/10/2020 | United Therapeutics Corp. | UTHR | Upgrade | Buy (Hold) |
98.26 (478.16) |
386.63% | Details | |
| 3/10/2020 | United Therapeutics Corp. | UTHR | Upgrade | Buy (Hold) |
98.26 (478.16) |
386.63% | Details | |
| 10/16/2019 | Alexion Pharmaceuticals | ALXN | Maintain | Hold (N/A) |
|
Details | ||
| 9/30/2019 | Deciphera | DCPH | New Coverage | Buy (N/A) |
32.86 (14.65) |
-55.42% | Details | |
| 8/1/2019 | United Therapeutics Corp. | UTHR | Upgrade | Hold (Underperform) |
79.53 (478.16) |
501.23% | Details | |
| 7/23/2019 | Ionis Pharmaceuticals | IONS | Maintain | Underperform (N/A) |
|
Details | ||
| 7/22/2019 | Translate Bio | TBIO | New Coverage | Buy (N/A) |
9.60 (29.15) |
203.65% | Details | |
| 7/22/2019 | BridgeBio Pharma | BBIO | New Coverage | Buy (N/A) |
26.00 (65.36) |
151.38% | Details | |
| 6/18/2019 | Ra Pharma | RARX | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2019 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2019 | Array BioPharma | ARRY | Downgrade | Hold (Buy) |
29.59 (6.81) |
-76.99% | Details | |
| 5/28/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2019 | Array BioPharma | ARRY | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2019 | La Jolla Pharma | LJPC | Upgrade | Hold (Underperform) |
6.10 (6.22) |
1.97% | Details | |
| 12/20/2018 | DBV Technologies S.A | DBVT | Downgrade | Hold (Buy) |
14.69 (21.87) |
48.88% | Details | |
| 10/30/2018 | Array BioPharma | ARRY | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2018 | AMAG Pharmaceuticals | AMAG | Maintain | Hold (N/A) |
|
Details |
